Home » Topics » BioWorld Science

BioWorld Science
RSS

Polyphenylene carboxymethylene shows anti-SARS-CoV-2 activity in vitro

Nov. 30, 2021

Scorpion Therapeutics unveils lead programs in cancer

Nov. 30, 2021

PNV-2 reduces metastases in animal model of triple-negative breast cancer

Nov. 30, 2021

Discovery of novel antifungal compounds with improved metabolic stability

Nov. 30, 2021

New transgenic hACE2-expressing mouse model shows efficacy of vaccine against brain COVID-19

Nov. 30, 2021

B-cell targeting controls chronic viral infections in mice

Nov. 30, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Eli Lilly and Company identifies CSF1R inhibitors

Nov. 30, 2021

Txinno Bioscience presents new ENPP1 inhibitors

Nov. 30, 2021

Dartmouth College discloses new GR antagonists

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...